PC_095 CIN II+ Detection Rates – Does Colposcopic Biopsy Strategy Matters? A multi-Center Analysis

Gabi Haran 1 , Liron Kogan 1,2 , Gadi Ben Shitrit 1 , Zvi Vaknin 3,4 , Avinoam Tzabari 5 ,
Yoav Baruch 1,4,6 1. Assuta Medical Centers, Colposcopy & Cervical pathology Unit, Israel. 2. HaEmek Medical Center, Department of Gynecology, Israel.; 3. Yitzhak Shamir Medical Center, Gynecologic Oncology Unit, Israel.  4. Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Tel Aviv, Israel. 5. Maayanei Hayeshua Medical Center, Department of Gynecology, Israel. 6. Ichilov Medical Center, Department of Gynecology, Israel

PC_072 Long-term HPV Clearance of APL-1702 in Patients with HSIL: A Post-Hoc Analysis of the APRICITY Study

L. Sui (1), F. Chen (2), P. Hillemanns (3), H. Ruan (4), X. Chen (5), Z. Novak (6), Y. Zhang (7), J. Su (8), L. Zhu (2), J. Lang (2)
(1) Obstetrics & Gynecology Hospital Of Fudan University, Shanghai, Chine, (2) Peking Union Medical College Hospital, Beijing, Chine, (3) Medizinische Hochschule Hannover, Hannover, Allemagne, (4) Nanjing Maternity And Child Health Hospital, Nanjing, Chine, (5) Wenzhou People’s Hospital, Wenzhou, Chine, (6) Aranyklinika Gynecology, Budapest, Hongrie, (7) Qilu Hospital Of Shandong University, Jinan, Chine, (8) Freelancer, Shanghai, Chine